Mohan A, Poulose R, Ansari A, Madan K, Hadda V, Khilnani G C, Guleria R
Department of Pulmonary Medicine and Sleep Disorders, All India Institute of Medical Sciences, New Delhi, India.
Indian J Cancer. 2017 Apr-Jun;54(2):478-480. doi: 10.4103/ijc.IJC_497_17.
Malnutrition is frequent in lung cancer and is measured using various tools, including the novel bioelectric impedance technique for measuring body composition. However, the validation of this technique for assessing body composition in advanced small cell lung cancer (SCLC) is untested.
Forty-one treatment naïve patients (all males) and an equal number of age- and sex-matched controls were evaluated by anthropometric measurements of skinfold thicknesses and body composition parameters such as body fat%, fat mass, fat-free mass (FFM), and total body water (TBW).
The mean (SD) age of the patient group was 55.7 (7.5) years, median pack-years was 20 (range, 0-80), and mean (SD) duration of symptoms was 152.6 (153.7) days. Median Karnofsky Performance Scale was 70 (range, 50-90). Majority of our patients (68.3%) were Stage IV followed by Stage III (31.7%). The percentage of patients with low, normal, and high body mass index (BMI) was 31.7%, 61%, and 7.3%, respectively. All components of body composition, i.e., body fat%, FFM, and TBW were significantly lower in patients compared to controls. However, the body composition in patients and controls with normal BMI was similar. The phenomenon of sarcopenia as a cause of cancer cachexia may explain these findings, whereas the combination of loss of body fat and lean body mass may lead to weight loss and reduced BMI.
Our results indicate that body composition is markedly altered in Indian patients with advanced SCLC. The impact of these parameters on clinically relevant outcomes needs further evaluation.
营养不良在肺癌患者中很常见,可通过多种工具进行评估,包括用于测量身体成分的新型生物电阻抗技术。然而,该技术在评估晚期小细胞肺癌(SCLC)身体成分方面的有效性尚未得到验证。
对41例未经治疗的患者(均为男性)以及数量相等的年龄和性别匹配的对照组进行评估,测量皮肤褶厚度等人体测量指标以及身体成分参数,如体脂百分比、脂肪量、去脂体重(FFM)和总体水(TBW)。
患者组的平均(标准差)年龄为55.7(7.5)岁,中位吸烟包年数为20(范围0 - 80),平均(标准差)症状持续时间为152.6(153.7)天。卡诺夫斯基功能状态评分中位数为70(范围50 - 90)。我们的大多数患者(68.3%)为IV期,其次是III期(31.7%)。体重指数(BMI)低、正常和高的患者百分比分别为31.7%、61%和7.3%。与对照组相比,患者身体成分的所有组成部分,即体脂百分比、FFM和TBW均显著降低。然而,BMI正常的患者和对照组的身体成分相似。肌肉减少症作为癌症恶病质的一个原因可能解释了这些发现,而体脂和瘦体重的减少可能导致体重减轻和BMI降低。
我们的结果表明,印度晚期SCLC患者的身体成分明显改变。这些参数对临床相关结果的影响需要进一步评估。